Trial · NCT02345161
Results by group462
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 462
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Trough Forced Expiratory Volume in One Second (FEV1) at Week 24 | FF/UMEC/VI 100/62.5/25 µg | 0.142 | Standard Error 0.0083 | Liters (L) | |
| Change From Baseline in Trough Forced Expiratory Volume in One Second (FEV1) at Week 24 | BUD/FOR 400/12 µg | -0.029 | Standard Error 0.0085 | Liters (L) | |
| Change From Baseline in Trough Forced Expiratory Volume in One Second (FEV1) at Week 52 | FF/UMEC/VI 100/62.5/25 µg | 0.126 | Standard Error 0.0170 | Liters (L) | |
| Change From Baseline in Trough Forced Expiratory Volume in One Second (FEV1) at Week 52 | BUD/FOR 400/12 µg | -0.053 | Standard Error 0.0172 | Liters (L) | |
| Change From Baseline in St George's Respiratory Questionnaire-Chronic Obstructive Pulmonary Disease (COPD; SGRQ) Total Score for COPD Participants at Week 24 | FF/UMEC/VI 100/62.5/25 µg | -6.6 | Standard Error 0.45 | Scores on a scale | |
| Change From Baseline in St George's Respiratory Questionnaire-Chronic Obstructive Pulmonary Disease (COPD; SGRQ) Total Score for COPD Participants at Week 24 | BUD/FOR 400/12 µg | -4.3 | Standard Error 0.46 | Scores on a scale | |
| Change From Baseline in St George's Respiratory Questionnaire-COPD; SGRQ Total Score for COPD Participants at Week 52 | FF/UMEC/VI 100/62.5/25 µg | -4.6 | Standard Error 1.01 | Scores on a scale | |
| Change From Baseline in St George's Respiratory Questionnaire-COPD; SGRQ Total Score for COPD Participants at Week 52 | BUD/FOR 400/12 µg | -1.9 | Standard Error 1.03 | Scores on a scale | |
| Transitional Dyspnea Index (TDI) Focal Score Expressed as Least Square Mean at Week 24 | FF/UMEC/VI 100/62.5/25 µg | 2.29 | Standard Error 0.096 | Scores on a scale | |
| Transitional Dyspnea Index (TDI) Focal Score Expressed as Least Square Mean at Week 24 | BUD/FOR 400/12 µg | 1.72 | Standard Error 0.099 | Scores on a scale | |
| Transitional Dyspnea Index (TDI) Focal Score Expressed as Least Square Mean at Week 52 | FF/UMEC/VI 100/62.5/25 µg | 1.74 | Standard Error 0.221 | Scores on a scale | |
| Transitional Dyspnea Index (TDI) Focal Score Expressed as Least Square Mean at Week 52 | BUD/FOR 400/12 µg | 1.39 | Standard Error 0.226 | Scores on a scale | |
| Daily Activity Question Percentage of Days Reporting a Score of 2 up to Week 24 | FF/UMEC/VI (100 mcg/62.5 mcg/25 mcg) | 0.0 | Standard Error 0.38 | Percentage of days | |
| Daily Activity Question Percentage of Days Reporting a Score of 2 up to Week 24 | Budesonide/Formoterol (400 mcg/12 mcg) | -0.1 | Standard Error 0.39 | Percentage of days | |
| Daily Activity Question Percentage of Days Reporting a Score of 2 up to Week 52 | FF/UMEC/VI 100/62.5/25 µg | 0.0 | Standard Error 0.70 | Percentage of days | |
| Daily Activity Question Percentage of Days Reporting a Score of 2 up to Week 52 | BUD/FOR 400/12 µg | 0.3 | Standard Error 0.69 | Percentage of days | |
| Mean Annual On-treatment Moderate and/or Severe COPD Exacerbations up to Week 24 | FF/UMEC/VI 100/62.5/25 µg | 0.22 | 95% Confidence Interval 0.18 to 0.28 | Exacerbations per participant per year | |
| Mean Annual On-treatment Moderate and/or Severe COPD Exacerbations up to Week 24 | BUD/FOR 400/12 µg | 0.34 | 95% Confidence Interval 0.28 to 0.42 | Exacerbations per participant per year | |
| Mean Annual On-treatment Moderate and/or Severe COPD Exacerbations up to Week 52 | FF/UMEC/VI 100/62.5/25 µg | 0.20 | 95% Confidence Interval 0.15 to 0.28 | Exacerbations per participant per year | |
| Mean Annual On-treatment Moderate and/or Severe COPD Exacerbations up to Week 52 | BUD/FOR 400/12 µg | 0.36 | 95% Confidence Interval 0.28 to 0.47 | Exacerbations per participant per year |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02345161/results